Graham Collins
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Graham Collins
Jun 21, 2024, 16:21 |
Insight
Graham Collins: Real world data from UK - Brexucel RR Mantle cell lymphoma
Graham Collins, Associate Professor, Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared…
Jun 21, 2024, 05:59 |
Blog
Results of ECHO study EHA
Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre,…
Jun 19, 2024, 13:46 |
Insight
David Russler-Germain: Swapping in BrECADD for PET adapted approaches
David Russler-Germain, Oncology Instructor at Siteman Cancer Center, shared a post by Graham Collins, Associate…
Jun 19, 2024, 07:45 |
Insight
Graham Collins: Starglo - A practice changing study
Graham Collins, Associate Professor of Hematology at the Oxford Cancer and Hematology Center shared a…
Sep 25, 2023, 16:24 |
Blog
Graham Collins: Reflections on being a new National Health Service (NHS) CAR T-cell centre.
Quoting Graham Collins, Associate Professor of Hematology at the Oxford Cancer and Hematology Center, on…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube